Akebia Therapeutics | AKBA - Процентные расходы





Процентные расходы Изменить Дата
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Akebia Therapeutics 4.83M 359.32M 2025-12
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amgen USD 653M 32M 2025-12
Ardelyx USD 5.76M 37K 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 10.19M 4.73M 2025-09
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Exelixis USD 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 85M 8.1M 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Ionis Pharmaceuticals USD 18M 0 2025-12
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
J&J USD 18M 290M 2025-09
Kangmei Pharma CNY 1.82M 150K 2025-09
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Medical Developments International AUD 18K 3K 2025-06
Moderna USD 12.14B 12.13B 2025-09
Nektar Therapeutics USD 6.02M 420K 2024-09
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pharma Mar EUR 117K 1.24M 2025-09
Prothena USD 2.62M 350M 2025-12
PTC Therapeutics USD 50.58M 2.59B 2025-12
Qiagen NV USD 10.14M 1.92M 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR -25M 252M 2025-12
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tectonic Therapeutic USD 12K 276.99M 2025-12
Tilray USD 6.7M 2.73M 2025-06
Vanda Pharmaceuticals 601.14M 23.61M 2025-09
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06